The heterogeneity was low for the 2 primary end points that we studied in the whole population and in the different subgroups, with the only exception being tumor PD-L1 status for 2-year EFS, which suggests caution in the interpretation of the reported association with the 2-year EFS reported in patients with negative PD-L1 tumor status. Here, CD274 is linked to neoplasm.